Amicus Therapeutics, Inc. (FOLD)
14.28
0.00 (0.00%)
USD |
NASDAQ |
Jan 09, 16:00
14.28
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Research and Development Expense (Quarterly): 23.42M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 188.52M |
| CorMedix, Inc. | 5.098M |
| ANI Pharmaceuticals, Inc. | 12.30M |
| Ekso Bionics Holdings, Inc. | 0.55M |
| Gilead Sciences, Inc. | 1.334B |